The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial
Open accessAbstract
Background: Remimazolam besylate is a newer benzodiazepine with characteristics of quick onset of effects, short maintenance and recovery times without accumulation in tissues. This trial was conducted to confirm the efficacy and safety of remimazolam besylate versus propofol during hysteroscopy. Methods: Patients undergoing hysteroscopy were randomly assigned to either the remimazolam (Group R) or the propofol group (Group P). Group R was administered an induction dose of 0.2 mg/kg and a maintenance dosage of 1.0 mg/kg/h. In Group P, propofol was started at 1.5–2.0 mg/kg and then maintained at 3.0–6.0 mg/kg/h. After remimazolam besylate or propofol induction, remifentanil was infused using a target-controlled infusion system with a target concentration of 1.5 ng/ml and titrated during the procedure. The incidence rates of injection pain, low oxygen saturation (SpO 2) and adverse effects in both groups were compared. Results: Eighty-two patients were included in this study. The incidence of adverse events in Group R (3.7%) was significantly lower than that in Group P (36.6%) (p < 0.001). The incidence of injection pain in Group P (80.5%) was much higher than that in Group R (2.4%) (p < 0.001). The incidence of other adverse events, such as low SpO 2, bradycardia, and hypotension in Group R was lower than that in Group P (p < 0.05). Conclusions: Remimazolam besylate proves to be a safer alternative for anesthesia during hysteroscopy. Moreover, adverse events caused by propofol, such as low SpO 2 and injection pain, are largely avoided. Trial registration: This study was approved by the Clinical Research Ethics Committee of Mengcheng County No. 1 People’s Hospital (2020MYL20003) and registered at http://www.chictr.org.cn (15/09/2020, ChiCTR-2000038252). The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doi, M., Morita, K., Takeda, J., Sakamoto, A., Yamakage, M., & Suzuki, T. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02788-6 · Cited by 484
Ye, T., & Yi, Y. (2017) · Statistical Theory and Related Fields · doi:10.1080/24754269.2017.1398000 · Cited by 19
Hu, K., Xiang, Q., Wang, Z., Sheng, X., Li, L., Liang, Y., Zhao, X., Ye, X., & Cui, Y. (2021) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.797 · Cited by 17 · cited 1×
“studies, remimazolam was effectively and safely used in Chinese volunteers [11, 25].”
Background
Cited by
Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent
Kilpatrick, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690875 · Cited by 262
Remimazolam: pharmacological characteristics and clinical applications in anesthesiology
Kim, K. M. (2022) · Anesthesia and Pain Medicine · doi:10.17085/apm.21115 · Cited by 257
Lu, K., Wei, S., Ling, W., Wei, Y., Ran, X., Huang, H., Wang, M., Wei, N., Liao, Y., Qin, Z., et al. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13797 · Cited by 71
Xin, Y., Chu, T., Wang, J., & Xu, A. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01805-3 · Cited by 45
Wei, A., Ma, S., Dou, Y., Wang, X., Wu, J., Zhou, S., Deng, Y., Liu, X., Li, D., & Yang, M. (2023) · PLOS ONE · doi:10.1371/journal.pone.0282930 · Cited by 33
Metadata
- Authors
- Zhang, X., Li, S., & Liu, J.
- Venue
- BMC Anesthesiology
- Published
- 2021-05-20
- Volume
- 21
- Issue
- 1
- Pages
- 156-156
- ISSN
- 1471-2253 (ISSN-L)
- OpenAlex
- W3131889944
- Cited by
- 165
- References
- 3
- FWCI
- 30.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12871-021-01373-y
- The paper
- Zhang, X., Li, S., & Liu, J. (2021). Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. BMC Anesthesiology. https://doi.org/10.1186/s12871-021-01373-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.